{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[14,2,14,3],[15,2,15,3],[17,2,17,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9911049197803321"]
[null,null,"Autore",null,"Kaundal Ravinder K"]
[null,null,"Titolo",null,"Drug Repurposing: Exploring Newer Therapeutic Potentials / / edited by Ravinder K. Kaundal, Rahul Shukla, Shubhini A. Saraf"]
[null,null,"Pubbl/distr/stampa",null,"Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2026"]
[null,null,"ISBN",null,"981-9545-22-6"]
[null,null,"Edizione",null,"[1st ed. 2026.]"]
[null,null,"Descrizione fisica",null,"1 online resource (532 pages)"]
[null,null,"Collana",null,"Biomedical and Life Sciences Series"]
[null,null,"Disciplina",null,"353.998"]
[null,null,"Soggetti",null,"Pharmacovigilance"]
[{"$nulls":4},"Drug delivery systems"]
[{"$nulls":4},"Therapeutics"]
[{"$nulls":4},"Drug Safety and Pharmacovigilance"]
[{"$nulls":4},"Drug Delivery"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"1. Role of Collaborative Industry and Academia in the Translational Success of Drug Repurposing -- 2. Drug Repurposing: Exploring Newer Therapeutic Potentials -- 3. Drug repurposing: Harnessing the therapeutics from antidiabetic molecules -- 4. Drug repurposing for cardioprotective therapy -- 5. Drug Repurposing in Autoimmune Disorder -- 6. COVID-19 management using drug repurposing -- 7. Drug repurposing: Case studies of prominent new use of old drugs -- 8. Challenges for drug repurposing: Special emphasis on Regulatory and Patent Issues -- 9. 3 R’s: Repurposing and Reformulation of therapeutics -- 10. QSAR-based studies for drug repurposing -- 11. Repurposing of Therapeutics for Anti-Cancer Activity -- 12. Drug repurposing for neurological disorders."]
[null,null,null,"Sommario/riassunto","The book explores the field of drug repurposing with a focus on past trends and developments. The book delves into the repurposing of bioactive phytomolecules and their applications in various therapeutic areas, including neurological disorders, diabetes, cardiovascular diseases, and autoimmune conditions. Additionally, it addresses the pressing need for repurposing drugs to combat infectious and neglected diseases, including an in-depth analysis of drug repurposing strategies in the management of COVID-19. Throughout the chapters, readers will find case studies highlighting prominent examples of repurposed drugs, challenges related to regulatory and patent issues, "]
[{"$nulls":4},"and the role of computational modelling and AI in accelerating drug discovery. This essential resource showcases how drug repurposing revolutionizes modern medicine and fosters a paradigm shift in pharmaceutical research. The book is a valuable resource for students, researchers, academicians, and pharmacologists."]